A

ALNY

Alnylam Pharmaceuticals Inc

273.00

Jul 21 • 12:35PM ET +0.33 (0.12%)

Healthcare Biotechnology USA Large NASD

Peers: ARGX REGN VRTX AMGN GILD BIIB BMRN ONC ABBV LLY

| Held by: VTI VO QQQ VUG VXF VOT IBB IWP CGGR QQQM

Scroll to Statements

Index	NDX
Market Cap	36.45B
Enterprise Value	36.41B
Income	577.22M
Sales	4.29B
Book/sh	8.06
Cash/sh	22.54
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2500
IPO	May 28, 2004

P/E	64.87
Forward P/E	25.23
PEG	0.31
P/S	8.50
P/B	33.88
P/C	12.11
P/FCF	56.83
EV/EBITDA	45.12
EV/Sales	8.49
Quick Ratio	3.06
Current Ratio	3.13
Debt/Eq	2.76
LT Debt/Eq	2.51
Option/Short	Yes / Yes

EPS (ttm)	4.21
EPS next Y	10.82
EPS next Q	1.61
EPS this Y	220.30%
EPS next Y	44.99%
EPS next 5Y	80.45%
EPS past 3/5Y	- -
Sales past 3/5Y	52.98% 49.77%
EPS Y/Y TTM	308.45%
Sales Y/Y TTM	82.57%
EPS Q/Q	440.32%
Sales Q/Q	96.43%
Earnings	Jul 30 BMO
EPS/Sales Surpr.	73.26% 4.63%

Insider Own	0.43%
Insider Trans	-9.58%
Inst Own	98.88%
Inst Trans	1.36%
ROA	12.36%
ROE	96.94%
ROIC	15.30%
Gross Margin	80.83%
Oper. Margin	17.54%
Profit Margin	13.46%
SMA20	-7.30%
SMA50	-6.89%
SMA200	-23.58%
Trades

Shs Outstand	133.44M
Shs Float	132.94M
Short Float	4.36%
Short Ratio	4.54
Short Interest	5.80M
52W High	495.55 -44.91%
52W Low	266.27 2.53%
Volatility	4.13% 4.84%
ATR (14)	13.98
RSI (14)	38.14
Beta	0.28
Rel Volume	0.46
Avg Volume	1.28M
Volume	293,576

Perf Week	-2.94%
Perf Month	-1.83%
Perf Quarter	-12.20%
Perf Half Y	-24.01%
Perf YTD	-31.35%
Perf Year	-14.83%
Perf 3Y	36.45%
Perf 5Y	51.59%
Perf 10Y	320.19%
Recom	1.66
Target Price	440.55
Prev Close	272.67
Price	273.00
Change	0.12%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)